Methoxsalen

Methoxsalen

SCHEMBL6142553

COc1c2occc2cc2ccc(=O)oc12.[LiH]

nearest known ligand 0.97

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 6/20 0.97
MAOA P21397 3/20 0.97
CYP1A2 P05177 2/20 0.97
CYP2A6 P11509 2/20 0.97
MAPK1 P28482 2/20 0.97
CYP2C19 P33261 2/20 0.97
CYP2D6 P10635 1/20 0.97
TSHR P16473 1/20 0.97
ACHE P22303 1/20 0.97
PDE4A P27815 1/20 0.97
SLC6A3 Q01959 1/20 0.97
CYP2A13 Q16696 1/20 0.97
KDM4E B2RXH2 6/20 0.68
HSD17B10 Q99714 4/20 0.68
POLB P06746 2/20 0.68
MAPT P10636 2/20 0.68
MAOB P27338 1/20 0.63
ALDH1A1 P00352 6/20 0.60
HPGD P15428 5/20 0.60
CA9 Q16790 5/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methoxsalen SCHEMBL2302069 0.98 CYP3A4 (1.00) CYP3A4MAOACYP1A2CYP2A6MAPK1
Methoxsalen SCHEMBL19168 0.98 CYP3A4 (1.00) CYP3A4MAOACYP1A2CYP2A6MAPK1
Methoxsalen SCHEMBL29376525 0.98 CYP3A4 (1.00) CYP3A4MAOACYP1A2CYP2A6MAPK1
Methoxsalen SCHEMBL9387169 0.91 CYP3A4 (0.86) CYP3A4MAOACYP1A2CYP2A6MAPK1
Methoxsalen SCHEMBL10572509 0.90 CYP3A4 (0.84) CYP3A4MAOACYP1A2CYP2A6MAPK1
Methoxsalen SCHEMBL598765 0.89 CYP3A4 (0.82) CYP3A4MAOACYP1A2CYP2A6MAPK1
Bergapten SCHEMBL9792363 0.85 CYP3A4 (0.74) CYP3A4MAOACYP1A2CYP2A6MAPK1
SCHEMBL7781220 0.82 CYP3A4 (0.72) CYP3A4MAOACYP1A2CYP2A6MAPK1
SCHEMBL8806449 0.82 CYP3A4 (0.71) CYP3A4MAOACYP1A2CYP2A6MAPK1
SCHEMBL13660657 0.82 CYP3A4 (0.71) CYP3A4MAOACYP1A2CYP2A6MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567134-A2 PHARMACEUTICAL COMPOSITIONS COMPRISING A BASIC RESPECTIVELY ACIDIC DRUG COMPOUND, A SURFACTANT AND A PHYSIOLOGICALLY TOLERABLE WATER-SOLUBLE ACID RESPECTIVELY BASE JANSSEN PHARMACEUTICA N.V. (BE) 2005-08-31 EP disclosed
WO-2004050068-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING A BASIC RESPECTIVELY ACIDIC DRUG COMPOUND, A SURFACTANT AND A PHYSIOLOGICALLY TOLERABLE WATER-SOLUBLE ACID RESPECTIVELY BASE JANSSEN PHARMACEUTICA N.V. (BE) 2004-06-17 WO disclosed
WO-2004050058-A2 PHARMACEUTICAL COMPOSITIONS COMPRISING A BASIC RESPECTIVELY ACIDIC DRUG COMPOUND, A SURFACTANT AND A PHYSIOLOGICALLY TOLERABLE WATER-SOLUBLE ACID RESPECTIVELY BASE JANSSEN PHARMACEUTICA N.V. (BE) 2004-06-17 WO disclosed
EP-0998304-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING CYCLODEXTRINS JANSSEN PHARMACEUTICA N.V. (BE) 2000-05-10 EP disclosed
WO-1998055148-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING CYCLODEXTRINS JANSSEN PHARMACEUTICA N.V. (BE) 1998-12-10 WO disclosed